In light of these considerations, we advocate further research on different ALS models and clinical trials aimed to investigate the synergistic effect and the mechanism of action of the combination of resveratrol with various HDAC inhibitors. This evidence concerns the gene HDAC9 and amyotrophic lateral sclerosis.